• Proactive MD Reports Third Transaction of 2026 

    On January 16, Proactive MD announced that it acquired undisclosed allergy specialist practices in Virginia. Terms were not disclosed.  Proactive MD is a value-based care provider dedicated to transforming healthcare for patients, employers and health plan partners through integrated solutions. Its integrated model offers centralized... Read More »
  • GSK Acquires Rapt Therapeutics For $2.2 Billion 

    In its first transaction of the year, GSK Plc, announced that it acquired Rapt Therapeutics, Inc. for $58 per share.  That price equates to an aggregate equity value of $2.2 billion, according to GSK, which added that the upfront investment net of cash acquired comes to $1.9 billion. Net of cash acquired, GSK’s estimated upfront investment... Read More »
  • Worldwide Clinical Trials to Acquire Catalyst Clinical Research

    Worldwide Clinical Trials, a global contract research organization (CRO), announced on January 20 that it will be acquiring Wilmington, North Carolina-headquartered Catalyst Clinical Research, LLC. Financial terms of the deal were not disclosed. Catalyst Clinical Research, LLC is a specialized CRO delivering customizable clinical research... Read More »
  • Most Active Physician Group Buyers of 2025

    The deal volume in the Physician Medical Group (PMG) sector was strong throughout 2025, totaling 521 transactions, surpassing the 506 reported in 2024. The subsectors with the most activity were dental (248 deals), eye care (34), dermatology (32) and orthopaedic (31).  The sector’s year-over-year stability is due to strong competition... Read More »
  • ACES Acquires Ally Pediatric Therapy

    ACES announced that it is bolstering its services in Arizona with the acquisition of Paradise Valley-based Ally Pediatric Therapy. Founded in 2017, Ally Pediatric Therapy is a leading provider of applied behavior analysis (ABA) therapy and speech-language therapy to children and young adults with autism and other childhood disorders. Ally... Read More »
Benefytt Technologies Gets New PE Investment

Benefytt Technologies Gets New PE Investment

Madison Dearborn Partners, the Chicago-based private equity firm, isn’t a major investor in the healthcare market, especially compared with some other firms, but it did announce a new acquisition in July. The private equity firm purchased Benefytt Technologies, Inc. (NASDAQ: BFYT) for $420.7 million. Madison Dearborn paid $31 cash per share (13.57 million shares), a 59% premium over the 30-day volume-weighted average price per share of Benefytt’s common stock through the close of trading on July 10, 2020.  Benefytt Technologies develops and operates private e-commerce health insurance marketplaces, purchaser engagement platforms, agency technology systems and insurance policy... Read More »
NMS Capital-Backed Physician Group Adds New Dermatology Practice

NMS Capital-Backed Physician Group Adds New Dermatology Practice

A portfolio company of NMS Capital announced in the last week of June it has acquired a Maryland-based dermatology practice, capping off a busy month for the private equity firm. Anne Arundel Dermatology Management (ADM) purchased Chevy Chase Cosmetic Center and Dermatology & Cosmetics Surgery Associates (CCCC), a dermatology practice founded in 1992 with four physicians and multiple locations in Chevy Chase and Greenbelt in Maryland. No terms were disclosed With the addition of CCCC, ADM now provides support services to over 65 clinic locations across four states and over 155 providers. CCCC will benefit from ADM’s administrative and support services, including investments in... Read More »
Private Equity Still Driving Behavioral Health Deals

Private Equity Still Driving Behavioral Health Deals

As healthcare M&A deal volume drops, particularly in the services sectors, behavioral health targets are still in hot demand, especially for private equity firms. Roughly 18% of deals announced by a PE buyer in the second quarter have targeted companies in the Behavioral Health Care sector, the highest concentration for any of the healthcare sectors. That statistic certainly correlates with the spike in demand for mental health services triggered by the anxiety surrounding COVID-19, as outlined in this article from The Chartis Group, an advisory and analytics services firm focused on the healthcare industry. Additionally, in early March, the U.S Centers for Medicare & Medicaid... Read More »

Private Equity in the Age of COVID-19

The effects of the COVID-19 on the healthcare M&A market will be difficult to discern for some time. Dealmaking takes a few months at least, so most announced transactions today were set in motion before the pandemic hit. The first quarter essentially dodged a bullet, but the start of Q2 is a much more precarious situation for investors and private equity. States are eager to loosen social distancing guidelines to boost the economy, but changing the public’s perceived risk of infection might not be so easy, so creating a rebound might prove a significant challenge. Hospitals and providers are still dealing with the flood of COVID-19 patients, cutting off revenues from elective... Read More »
Blue Sprig Pediatrics Acquires ABA Providers

Blue Sprig Pediatrics Acquires ABA Providers

BlueSprig Pediatrics, with the backing of KKR & Co. (NYSE: KKR), has been an active player in the M&A field. Since BlueSprig was formed in October 2018, it has reported five behavioral health care transactions in three different states, according to our Deal Search Online database. Now it has a foothold in Florida. Last week the company announced its acquisition of Florida Autism Center and Fusion Autism Center for $120 million. Collectively called FAC, the group provides applied behavior analysis (ABA) therapy services treating children with autism spectrum disorder. This partnership will create a top-five national provider and the leading provider in the southern United States.... Read More »
Retina Consultants of America Formed through PE-Backed Merger

Retina Consultants of America Formed through PE-Backed Merger

And in one fell swoop, Webster Equity Partners has formed a major physician group. The private equity firm announced in early March that it is acquiring and merging Retina Consultants of Houston, Retina Group of Florida, Long Island Vitreoretinal Consultants, and Retinal Consultants Serving Northern California to form Retina Consultants of America (RCA). The platform has a $350 million investment to build on and will have EBITDA of $80 million and roughly 50 physicians, according to sources cited in PEHub. But tucked away in that price is a fifth transaction that we should hear about before the end of March. Further, Webster and RCA are planning to expand rapidly, adding more practices in... Read More »